Top Stories
By Hyunjoo Jin SEOUL/SAN FRANCISCO (Reuters) -Samsung Electronics on Wednesday unveiled its…
BioVaxys Technology Corp. is developing its patented DPX™ platform to address the challenges of lipid nanoparticles (LNPs) in mRNA vaccine delivery. Learn how DPX improves stability, immune responses, and manufacturing economics as the mRNA vaccine market projects $48 billion growth by 2030.
By Hyunjoo Jin SEOUL/SAN FRANCISCO (Reuters) -Samsung Electronics on Wednesday unveiled…
By David Shepardson and Lananh Nguyen WASHINGTON (Reuters) – The Senate…
By Leika Kihara (Reuters) -The Bank of Japan concludes its first…
By Jihoon Lee SEOUL (Reuters) -South Korea’s economy barely grew in…
Investments
China is guiding its local mutual funds and insurers to boost investments…
Economy Insights
National News
First Busey Corporation (NASDAQ:BUSE) will increase its dividend on the 31st of January to $0.25, which is 4.2% higher than last year’s payment from the same period…
New York, New York–(Newsfile Corp. – January 20, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on…
Image source: Getty Images Space Exploration Technologies Corp, or SpaceX, is one of the most exciting growth companies in the world. Unfortunately, everyday investors can’t buy shares…
LONDON – Penarth Master Issuer PLC has notified holders of its £1.3 billion Series 2013-1 A2 Class A Asset Backed Floating Notes that amendments to the terms…
Big banks are sounding and acting a lot more like private equity. The latest example came last week as Goldman Sachs (GS), one of the oldest and…
Image source: Getty Images By lunchtime today (20 January), Reach (LSE:RCH) was the third-best-performing stock on the FTSE. Its rise of 23% followed the release of a…